Trust analysts at Winterflood have highlighted their favoured biotech and healthcare trusts, as the sector continues its comeback after the threat of significant political reform was reduced following Donald Trump's win in the US Presidential Election a year ago.
The average discount for the AIC's Biotechnology and Healthcare sector has tightened from a weighted average of 5% a year ago to 0% today, while all but one of the funds in existence for more than a year...
Revealed – successes across all 11 categories
Latest news and analysis
Letter from academics
'Digital transformation' of sector
Up from 14% in 2017